Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling is a research paper published in Biology of Blood and Marrow Transplantation (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: P30 CA008748
NIAMS NIH HHS
Grant: R01 AR059357
BLRD VA
Grant: IK6 BX004596
NCI NIH HHS
Grant: U24 CA076518
NHLBI NIH HHS
Grant: UG1 HL138645
NCI NIH HHS
Grant: R01 CA241677
NHLBI NIH HHS
Grant: U10 HL069294
NHLBI NIH HHS
Grant: UG1 HL069315
NHLBI NIH HHS
Grant: U24 HL138660
FWCI
0.57
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals